China Medical System Holdings Limited (CHSYF)

Market Cap	2.62B
Revenue (ttm)	965.23M
Net Income (ttm)	191.32M
Shares Out	n/a
EPS (ttm)	0.08
PE Ratio	13.70
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	110
Average Volume	1,841
Open	0.931
Previous Close	0.931
Day's Range	0.931 - 0.931
52-Week Range	0.931 - 1.518
Beta	0.83
RSI	36.95
Earnings Date	Mar 14, 2025

About CHSYF

China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China. Its products include VALTOCO, a diazepam nasal spray to treat seizure clusters; Plendil for the treatment of hypertension and stable angina pectoris; XinHuoSu to treat acute heart failure; Deanxit for mild-to-moderate depression, anxiety, and psychosomatic affections; METOJECT, a methotrexate injection for recalcitrant disabling psoriasis; and Ursofalk for the treatment of ch...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1995
• Employees: 5,701
• Stock Exchange: OTCMKTS
• Ticker Symbol: CHSYF

Financial Performance

In 2023, CHSYF's revenue was 8.01 billion, a decrease of -12.43% compared to the previous year's 9.15 billion. Earnings were 2.40 billion, a decrease of -26.33%.

Financial numbers in CNY